Literature DB >> 9054418

Substrate and inhibitor specificity of interleukin-1 beta-converting enzyme and related caspases.

N Margolin1, S A Raybuck, K P Wilson, W Chen, T Fox, Y Gu, D J Livingston.   

Abstract

Interleukin-1beta-converting enzyme (ICE) is a novel cysteine protease responsible for the cleavage of pre-interleukin-1beta (pre-IL-1beta) to the mature cytokine and a member of a family of related proteases (the caspases) that includes the Caenorhabditis elegans cell death gene product, CED-3. In addition to their sequence homology, these cysteine proteases display an unusual substrate specificity for peptidyl sequences with a P1 aspartate residue. We have examined the kinetics of processing pre-IL-1beta to the mature form by ICE and three of its homologs, TX, CPP-32, and CMH-1. Of the ICE homologs, only TX processes pre-IL-1beta, albeit with a catalytic efficiency 250-fold less than ICE itself. We also investigated the ability of these four proteases to process poly(ADP-ribose) polymerase, a DNA repair enzyme that is cleaved within minutes of the onset of apoptosis. Every caspase examined cleaves PARP, with catalytic efficiencies ranging from 2.3 x 10(6) M-1 s-1 for CPP32 to 1.0 x 10(3) M-1 s-1 for TX. In addition, we report kinetic constants for several reversible inhibitors and irreversible inactivators, which have been used to implicate one or more caspases in the apoptotic proteolysis cascade. Ac-Asp-Glu-Val-Asp aldehyde (DEVD-CHO) is a potent inhibitor of CPP-32 with a Ki value of 0.5 nM, but is also potent as inhibitor of CMH-1 (Ki = 35 nM) and ICE (Ki = 15 nM). The x-ray crystal structure of DEVD-CHO complexed to ICE presented here reveals electrostatic interactions not present in the Ac-YVAD-CHO co-complex structure (Wilson, K. P., Black, J.-A. F., Thomson, J. A., Kim, E. E., Griffith, J. P., Navia, M. A., Murcko, M. A., Chambers, S. P., Aldape, R. A., Raybuck, S. A., and Livingston, D. J. (1994) Nature 370, 270-275), accounting for the surprising potency of this inhibitor against ICE.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054418     DOI: 10.1074/jbc.272.11.7223

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Poly(ADP-ribosylation) and apoptosis.

Authors:  A I Scovassi; G G Poirier
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

2.  Characterization of nicotinamidases: steady state kinetic parameters, classwide inhibition by nicotinaldehydes, and catalytic mechanism.

Authors:  Jarrod B French; Yana Cen; Tracy L Vrablik; Ping Xu; Eleanor Allen; Wendy Hanna-Rose; Anthony A Sauve
Journal:  Biochemistry       Date:  2010-11-15       Impact factor: 3.162

3.  Activation of caspases in pig kidney cells infected with wild-type and CrmA/SPI-2 mutants of cowpox and rabbitpox viruses.

Authors:  J Macen; A Takahashi; K B Moon; R Nathaniel; P C Turner; R W Moyer
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  A genetic screen for the isolation and characterization of site-specific proteases.

Authors:  H J Sices; T M Kristie
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

5.  Commitment and effector phases of the physiological cell death pathway elucidated with respect to Bcl-2 caspase, and cyclin-dependent kinase activities.

Authors:  K J Harvey; J F Blomquist; D S Ucker
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

6.  Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells.

Authors:  W C Hung; H C Chang; L Y Chuang
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

7.  Structural modeling and functional analysis of the essential ribosomal processing protease Prp from Staphylococcus aureus.

Authors:  Erin A Wall; Adam L Johnson; Darrell L Peterson; Gail E Christie
Journal:  Mol Microbiol       Date:  2017-03-02       Impact factor: 3.501

8.  Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome.

Authors:  Ashish K Rehni; Nirmal Singh; Mahesh Rachamalla; Kulbhushan Tikoo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-25       Impact factor: 3.000

9.  Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase.

Authors:  Sanjeev Kumar; Daniel Jaller; Bhumika Patel; Judith M LaLonde; James B DuHadaway; William P Malachowski; George C Prendergast; Alexander J Muller
Journal:  J Med Chem       Date:  2008-07-30       Impact factor: 7.446

10.  VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis.

Authors:  Peter Weber; Ping Wang; Stephane Maddens; Paul Sh Wang; Rongqian Wu; Michael Miksa; Weifeng Dong; Michael Mortimore; Julian M C Golec; Peter Charlton
Journal:  Crit Care       Date:  2009-09-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.